3rd GLP-1-Based Therapeutics Summit 2026

Meet
Nick Maragos
VP – Business Development

Nitin Mittal
AVP – Business Development
at our booth

Join the session:
Enabling GLP-1 Commercial Success through Drug–Device Readiness

  • Drug–device readiness is a commercial differentiator for GLP-1s
  • Integrated formulation–DP–device approach reduces risk and timelines
  • Early device strategy enables scalable growth